Arix Bioscience Plc - Notice of Results
Notice of Results
(“Arix”, LSE: ARIX) a global venture capital company focused on investing in and building breakthrough biotech companies, will announce its interim results for the six months ended , on Wednesday, ., :
A presentation and webcast for analysts will be held on the day of results at at the , , , EC2M 4YD. Details of the webcast will be available on request. The webcast will be recorded, and a replay will be available on the Company's website at
For more information on Arix, please contact:
, Head of Investor Relations
+44 (0)20 7290 1072
T: +44 (0) 203 950 9144
is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences.
We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.
For further information, please visitwww.arixbioscience.com
Quick facts: Arix Bioscience PLC
Market Cap: £84.72 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE